1
|
Weber C and Noels H: Atherosclerosis:
Current pathogenesis and therapeutic options. Nat Med.
17:1410–1422. 2011. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Roth GA, Johnson C, Abajobir A, Abd-Allah
F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, et al:
Global, regional, and national burden of cardiovascular diseases
for 10 causes, 1990 to 2015. J Am Coll Cardiol. 70:1–25. 2017.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Johnson JL: Emerging regulators of
vascular smoothmuscle cell function in the development and
progression of atherosclerosis. Cardiovasc Res. 103:452–460. 2014.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Ross R: Atherosclerosis-an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
6
|
Hutcheson JD, Goettsch C, Bertazzo S,
Maldonado N, Ruiz JL, Goh W, Yabusaki K, Faits T, Bouten C, Franck
G, et al: Genesis and growth of extracellular-vesicle-derived
microcalcification in atherosclerotic plaques. Nat Mater.
15:335–343. 2016. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Millette E, Rauch BH, Kenagy RD, Daum G
and Clowes AW: Platelet-derived growth factor-BB transactivates the
fibroblast growth factor receptor to induce proliferation in human
smooth muscle cells. Trends Cardiovasc Med. 16:25–28. 2006.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Raines EW: PDGF and cardiovascular
disease. Cytokine Growth Factor Rev. 15:237–254. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
11
|
Yang X, Dong M, Wen H, Liu X, Zhang M, Ma
L, Zhang C, Luan X, Lu H and Zhang Y: MiR-26a contributes to the
PDGF-BB-induced phenotypic switch of vascular smooth muscle cells
by suppressing Smad1. Oncotarget. 8:75844–75853. 2017.PubMed/NCBI
|
12
|
Yang J, Zeng P, Yang J, Liu X, Ding J,
Wang H and Chen L: MicroRNA-24 regulates vascular remodeling via
inhibiting PDGF-BB pathway in diabetic rat model. Gene. 659:67–76.
2018. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen C, Yan Y and Liu X: microRNA-612 is
downregulated by platelet-derived growth factor-BB treatment and
has inhibitory effects on vascular smooth muscle cell proliferation
and migration via directly targeting AKT2. Exp Ther Med.
15:159–165. 2018.PubMed/NCBI
|
14
|
Zhang RH, Sui L, Hong XJ, Yang M and Li
WM: MiR-448 promotes vascular smooth muscle cell proliferation and
migration in through directly targeting MEF2C. Environ Sci Pollut
Res Int. 24:22294–22300. 2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wang J, Wang X, Wu G, Hou D and Hu Q:
miR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle
progression and apoptosis of human retinoblastoma cells by
targeting PAX6. FEBS Lett. 587:1779–1786. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Tang BL: ADAMTS: A novel family of
extracellular matrix proteases. Int J Biochem Cell Biol. 33:33–44.
2001. View Article : Google Scholar : PubMed/NCBI
|
17
|
Jönsson-Rylander AC, Nilsson T,
Fritsche-Danielson R, Hammarström A, Behrendt M, Andersson JO,
Lindgren K, Andersson AK, Wallbrandt P, Rosengren B, et al: Role of
ADAMTS-1 in atherosclerosis: Remodeling of carotid artery,
immunohistochemistry, and proteolysis of versican. Arterioscler
Thromb Vasc Biol. 25:180–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li M, Liu Q, Lei J, Wang X, Chen X and
Ding Y: miR-362-3p inhibits the proliferation and migration of
vascular smooth muscle cells in atherosclerosis by targeting
ADAMTS1. Biochem Biophys Res Commun. 493:270–276. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Vong S and Kalluri R: The role of stromal
myofibroblast and extracellular matrix in tumor angiogenesis. Genes
Cancer. 2:1139–1145. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kuno K, Okada Y, Kawashima H, Nakamura H,
Miyasaka M, Ohno H and Matsushima K: ADAMTS-1 cleaves a cartilage
proteoglycan, aggrecan. FEBS Lett. 478:241–245. 2000. View Article : Google Scholar : PubMed/NCBI
|
23
|
Rucci N, Sanità P and Angelucci A: Roles
of metalloproteases in metastatic niche. Curr Mol Med. 11:609–622.
2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hart IR and Saini A: Biology of tumour
metastasis. Lancet. 339:1453–1457. 1992. View Article : Google Scholar : PubMed/NCBI
|
25
|
Tan Ide A, Ricciardelli C and Russell DL:
The metalloproteinase ADAMTS1: A comprehensive review of its role
in tumorigenic and metastatic pathways. Int J Cancer.
133:2263–2276. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Gustavsson H, Tesan T, Jennbacken K, Kuno
K, Damber JE and Welén K: ADAMTS1 alters blood vessel morphology
and TSP1 levels in LNCaP and LNCaP-19 prostate tumors. Bmc Cancer.
10:2882010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Fletcher SJ, Sacca PA, Pistone-Creydt M,
Coló FA, Serra MF, Santino FE, Sasso CV, Lopez-Fontana CM, Carón
RW, Calvo JC and Pistone-Creydt V: Human breast adipose tissue:
Characterization of factors that change during tumor progression in
human breast cancer. J Exp Clin Cancer Research. 36:262017.
View Article : Google Scholar
|
28
|
Kohno T, Otsuka A, Girard L, Sato M,
Iwakawa R, Ogiwara H, Sanchez-Cespedes M, Minna JD and Yokota J: A
Catalog of genes homozygously deleted in human lung cancer and the
candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes
Cancer. 49:342–352. 2010.PubMed/NCBI
|
29
|
Mullany LE, Herrick JS, Wolff RK and
Slattery ML: Single nucleotide polymorphisms within MicroRNAs,
MicroRNA targets, and MicroRNA biogenesis genes and their impact on
colorectal cancer survival. Genes Chromosomes Cancer. 56:285–295.
2017. View Article : Google Scholar : PubMed/NCBI
|
30
|
Lee YJ, Koch M, Karl D, Torres-Collado AX,
Fernando NT, Rothrock C, Kuruppu D, Ryeom S, Iruela-Arispe ML and
Yoon SS: Variable inhibition of thrombospondin 1 against liver and
lung metastases through differential activation of
metalloproteinase ADAMTS1. Cancer Res. 70:948–956. 2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
De Schutter A, Lavie CJ and Milani RV: The
impact of obesity on risk factors and prevalence and prognosis of
coronary heart disease-the obesity paradox. Prog Cardiovasc Dis.
56:401–408. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Williams KJ: Arterial wall chondroitin
sulfate proteoglycans: Diverse molecules with distinct roles in
lipoprotein retention and atherogenesis. Curr Opin Lipidol.
12:477–487. 2001. View Article : Google Scholar : PubMed/NCBI
|
33
|
Wight TN: Versican: A versatile
extracellular matrix proteoglycan in cell biology. Curr Opin Cell
Biol. 14:617–623. 2002. View Article : Google Scholar : PubMed/NCBI
|
34
|
Vorkapic E, Folkesson M, Magnell K,
Bohlooly YM, Länne T and Wågsäter D: ADAMTS-1 in abdominal aortic
aneurysm. PLoS One. 12:e01787292017. View Article : Google Scholar : PubMed/NCBI
|
35
|
Gao Y, Wu W, Yu C, Zhong F, Li G, Kong W
and Zheng J: A disintegrin and metalloproteinase with
thrombospondin motif 1 (ADAMTS1) expression increases in acute
aortic dissection. Sci China Life Sci. 59:59–67. 2016. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wahid F, Shehzad A, Khan T and Kim YY:
MicroRNAs: Synthesis, mechanism, function, and recent clinical
trials. Biochim Biophys Acta. 1803:1231–1243. 2010. View Article : Google Scholar : PubMed/NCBI
|
37
|
Bayoumi AS, Aonuma T, Teoh JP, Tang YL and
Kim IM: Circular noncoding RNAs as potential therapies and
circulating biomarkers for cardiovascular diseases. Acta Pharmacol
Sin. 39:1100–1109. 2018. View Article : Google Scholar : PubMed/NCBI
|
38
|
Pordzik J, Pisarz K, De Rosa S, Jones AD,
Eyileten C, Indolfi C, Malek L and Postula M: The potential role of
platelet-related microRNAs in the development of cardiovascular
events in high-risk populations, including diabetic patients: A
review. Front Endocrinol (Lausanne). 9:742018. View Article : Google Scholar : PubMed/NCBI
|
39
|
Zhang HW, Li H, Yan H and Liu BL:
MicroRNA-142 promotes the expression of eNOS in human peripheral
blood-derived endothelial progenitor cells in vitro. Eur Rev Med
Pharmacol Sci. 20:4167–4175. 2016.PubMed/NCBI
|
40
|
Li M, Liu L, Zang W, Wang Y, Du Y, Chen X,
Li P, Li J and Zhao G: miR365 overexpression promotes cell
proliferation and invasion by targeting ADAMTS-1 in breast cancer.
Int J Oncol. 47:296–302. 2015. View Article : Google Scholar : PubMed/NCBI
|
41
|
Liu L, Yin H, Huang M, He J, Yi G, Wang Z
and Qian H: miR-21 promotes pulmonary fibrosis in rats via
down-regulating the expression of ADAMTS-1. Xi Bao Yu Fen Zi Mian
Yi Xue Za Zhi. 32:1636–1640. 2016.(In Chinese). PubMed/NCBI
|
42
|
Pan B, Toms D, Shen W and Li J:
MicroRNA-378 regulates oocyte maturation via the suppression of
aromatase in porcine cumulus cells. Am J Physiol Endocrinol Metab.
308:E525–E534. 2015. View Article : Google Scholar : PubMed/NCBI
|
43
|
Chen SZ, Ning LF, Xu X, Jiang WY, Xing C,
Jia WP, Chen XL, Tang QQ and Huang HY: The miR-181d-regulated
metalloproteinase Adamts1 enzymatically impairs adipogenesis via
ECM remodeling. Cell Death Differ. 23:1778–1791. 2016. View Article : Google Scholar : PubMed/NCBI
|
44
|
Anglicheau D, Muthukumar T and
Suthanthiran M: MicroRNAs: Small RNAs with big effects.
Transplantation. 90:105–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
45
|
Witkos TM, Koscianska E and Krzyzosiak WJ:
Practical aspects of microRNA target prediction. Curr Mol Med.
11:93–109. 2011. View Article : Google Scholar : PubMed/NCBI
|